
Aimmune starts POSEIDON trial to treat peanut allergy
Aimmune Therapeutics has commenced the Peanut Oral Immunotherapy Study of Early Intervention for Desensitisation (POSEIDON) trial.
Aimmune Therapeutics has commenced the Peanut Oral Immunotherapy Study of Early Intervention for Desensitisation (POSEIDON) trial.
Thank you for subscribing to Clinical Trials Arena